Delta Eight Pharmaceuticals Inc

Delta Eight Pharmaceuticals is a Canadian advisory and research consultancy focused on evidence translation, regulatory governance, and risk in emerging therapies.

We support healthcare organizations, researchers, and innovation leaders navigating areas where regulation, clinical evidence, and real-world patient experience do not yet align—a challenge that has direct implications for the safe and defensible use of clinical decision support tools, including AI.

Drawing on decades of experience working within highly regulated therapeutic environments, Delta Eight provides system-level insight into how regulatory frameworks, post-market surveillance, and evidence standards shape clinical risk, accountability, and trust. Our work is non-promotional and governance-focused, helping decision-makers assess when innovation is ready for adoption—and when safeguards are still required.

Delta Eight’s perspective is particularly relevant in contexts involving emerging therapies, real-world evidence, and AI governance, where incomplete or constrained data can introduce unintended risk if not properly understood and managed.